z-logo
open-access-imgOpen Access
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity
Author(s) -
Francesco Borriello,
Valentina Poli,
Ellen Shrock,
Roberto Spreafico,
Xin Liu,
Novalia Pishesha,
Claire Carpenet,
Janet Chou,
Marco Di Gioia,
Marisa E. McGrath,
Carly Dillen,
Nora A. Barrett,
Lucrezia Lacanfora,
Marcella E. Franco,
Laura Marongiu,
Yoichiro Iwakura,
Ferdinando Pucci,
Michael Kruppa,
Zuchao Ma,
Douglas W. Lowman,
Harry E. Ensley,
Etsuro Nanishi,
Yoshine Saito,
Timothy R. O’Meara,
HyukSoo Seo,
Sirano DhePaga,
David J. Dowling,
Matthew B. Frieman,
Stephen J. Elledge,
Ofer Levy,
Darrell J. Irvine,
Hidde L. Ploegh,
David L. Williams,
Ivan Zai
Publication year - 2022
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2022.01.009
Subject(s) - biology , immunogenicity , adjuvant , antigen , computational biology , immunology
Activation of the innate immune system via pattern recognition receptors (PRRs) is key to generate lasting adaptive immunity. PRRs detect unique chemical patterns associated with invading microorganisms, but whether and how the physical properties of PRR ligands influence the development of the immune response remains unknown. Through the study of fungal mannans, we show that the physical form of PRR ligands dictates the immune response. Soluble mannans are immunosilent in the periphery but elicit a potent pro-inflammatory response in the draining lymph node (dLN). By modulating the physical form of mannans, we developed a formulation that targets both the periphery and the dLN. When combined with viral glycoprotein antigens, this mannan formulation broadens epitope recognition, elicits potent antigen-specific neutralizing antibodies, and confers protection against viral infections of the lung. Thus, the physical properties of microbial ligands determine the outcome of the immune response and can be harnessed for vaccine development.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom